Pulmotect, Inc.
  • Home
  • About Us
    • Our Company
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Our Approach
    • Overview
    • Our Science
    • Our Pipeline
    • Published Journal Articles
  • News
  • Contact Us

Houston company working on possible COVID-19 treatment

Posted on March 30, 2020 by Brenton Scott
Posted in News Coverage

Post navigation

Houston biotech co.’s coronavirus treatment candidate to undergo clinical trials
Pulmotect receives FDA approval to commence two Phase-2 trials targeting COVID-19
Pulmotect Inc

3900 Essex Ln, Suite 575
Houston, TX 77027
Contact Us

© 2023
Pulmotect, Inc.